Literature DB >> 7229915

Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.

J A Jansen.   

Abstract

The potential influence of protein binding kinetics on elimination from liver sinusoids was evaluated by means of a "well-stirred" model (I) and a "tube" model (II). When the dissociation rate constant (k-1) is at the estimated maximum, equilibrium is maintained during the passage of drug through the eliminating organ, and hence dissociation as such has no limiting effect on elimination. When, however, k-1 is at the estimated minimum, equilibrium is not maintained, the unbound fraction is reduced during the passage, and a significant decrease in the extraction ratio occurs when the unbound fraction is 0.01 or less. The models were furthermore used to investigate the effect of saturation, of both the binding protein and the elimination process, on elimination.

Mesh:

Substances:

Year:  1981        PMID: 7229915     DOI: 10.1007/bf01059340

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  21 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

3.  [Hemodynamics of kidney medullary substance. Part I. Capillary passage time, blood volume, circulation, tissue hematocrit and oxygen consumption of kidney medullary substance in situ].

Authors:  K KRAMER; K THURAU; P DEETJEN
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1960

4.  Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.

Authors:  J G Wagner
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

5.  Kinetics of the binding of salicylazosulfapyridine to human serum albumin.

Authors:  J A Jansen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-11

6.  A new method for the determination of sodium and potassium in human red blood cells, using indocyanine green as a marker for trapped plasma.

Authors:  L Vettore; G Falezza; M C De Matteis; G Cetto; M Zandegiacomo
Journal:  Clin Chim Acta       Date:  1974-09-30       Impact factor: 3.786

7.  Numerical solution of nonlinear pharmacokinetic equations: effects of plasma protein binding on drug distribution and elimination.

Authors:  J J Coffey; F J Bullock; P T Schoenemann
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

8.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

9.  Pharmacokinetic models regarding protein binding of drugs.

Authors:  E Krüger-Thiemer; W Diller; P Bünger
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

10.  Kinetics of elimination of drugs possessing high affinity for the plasma proteins.

Authors:  B K Martin
Journal:  Nature       Date:  1965-08-28       Impact factor: 49.962

View more
  11 in total

1.  At physiologic albumin/oleate concentrations oleate uptake by isolated hepatocytes, cardiac myocytes, and adipocytes is a saturable function of the unbound oleate concentration. Uptake kinetics are consistent with the conventional theory.

Authors:  D Sorrentino; R B Robinson; C L Kiang; P D Berk
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

2.  Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.

Authors:  M E Morris; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

3.  Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver.

Authors:  R A Weisiger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration.

Authors:  P A Sjöström; B G Kron; B G Odlind
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Protein binding and drug clearance.

Authors:  M Rowland
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

6.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

7.  Hepatic elimination of drugs with concentration-dependent serum protein binding.

Authors:  J D Huang; S Oie
Journal:  J Pharmacokinet Biopharm       Date:  1984-02

8.  Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.

Authors:  T Terasaki; Y Sugiyama; T Iga; Y Sawada; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

9.  Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.

Authors:  X Xu; P Selick; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

10.  Binding of sulfonamides to carbonic anhydrase: influence on distribution within blood and on pharmacokinetics.

Authors:  A Boddy; P Edwards; M Rowland
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.